Krishna Institute of Medical Sciences Share News - Latest Updates, Live News & More

Latest news about Krishna Institute of Medical Sciences

KIMS Hospitals Q2 FY26: Revenue Surges 23.3% Despite Margin Pressure from New Hospital Ramp-up 10 days ago

Krishna Institute of Medical Sciences reported a 23.3% year-on-year revenue growth to INR 965.00 crores in Q2 FY26. However, EBITDA declined by 6.7% to INR 208.00 crores, and PAT dropped to INR 72.00 crores from INR 121.00 crores last year. The EBITDA margin contracted to 21.6% from 28.5% due to losses from newly commissioned hospitals. IP volume grew by 15.3%, and OP volume increased by 25.1%. The company expects new facilities to achieve EBITDA breakeven within 12 months and anticipates benefits from a 20% CGHS price hike from Q4 FY26.

KIMS Hospitals Reports 23% Revenue Growth Amid Margin Pressure in Q2FY26 Nov 12, 2025

KIMS Hospitals Expands with New Facilities and Enhanced Services Nov 11, 2025

KIMS Hospitals Reports 23.3% Revenue Growth in Q2 FY26, Expands Footprint Across South India Nov 07, 2025

KIMS Hospitals Reports Q2 FY26 Results: Revenue Up, Profit Down Nov 07, 2025

More news about Krishna Institute of Medical Sciences

27Oct 25

Krishna Institute of Medical Sciences Sees Significant Block Trade Worth Rs. 71.89 Crores

Krishna Institute of Medical Sciences (KIMS) experienced a significant block trade on the National Stock Exchange (NSE). The transaction involved 1,003,735 shares traded at Rs. 716.25 per share, totaling Rs. 71.89 crores. This large-scale trade suggests substantial institutional interest in KIMS stock and may influence short-term trading patterns.

15Sept 25

Krishna Institute Of Medical Sciences Launches 450-Bed Hospital in Bengaluru, Marking Strategic Expansion

Krishna Institute of Medical Sciences (KIMS) has opened a new 450-bed multi-specialty hospital in Mahadevapura, Bengaluru, marking its entry into the city's healthcare market. The facility includes over 120 ICU beds, more than 100 OPD beds, and covers 35+ medical and surgical specialties. This expansion, operated by KIMS Hospital Bengaluru Private Limited, a wholly-owned subsidiary, represents a strategic move to strengthen KIMS' presence in Southern India and tap into Bengaluru's growing healthcare demand.

23Aug 25

KIMS Targets 25-30% Annual Revenue Growth, Plans to Boost ARPOB to Rs 55,000

Krishna Institute of Medical Sciences (KIMS) has announced plans for 25-30% year-on-year revenue growth over the next 3-4 years. The company aims to increase Average Revenue Per Occupied Bed from Rs 43,000 to Rs 55,000. KIMS is expanding with 900 new beds this year in Bangalore and Thane. The company's current debt-to-EBITDA ratio is less than 1:1, but rises to 2.5 when including subsidiaries. Management intends to optimize this ratio to 1.5-2. Despite positive outlook, KIMS' stock closed 0.96% lower at Rs 739.00 on NSE.

06Aug 25

KIMS Hospitals Reports Strong Q1 FY26 Growth, Expands Footprint with New Projects

Krishna Institute of Medical Sciences (KIMS Hospitals) reported robust Q1 FY26 results with total revenue of ₹879.00 crore, up 26.80% year-on-year. EBITDA reached ₹200.00 crore with a 22.70% margin. The company saw significant increases in inpatient and outpatient volumes. KIMS is pursuing expansion projects in Bengaluru, Ongole, Anantapur, Kondapur, and Rajahmundry, adding over 1,900 beds across these locations. A new 300+ bed facility was also opened in Thane, Maharashtra. Dr. B Bhaskar Rao, CMD, expressed optimism about meeting FY26 targets.

06Aug 25

KIMS Hospitals Reports 26.8% Revenue Growth to ₹879 Cr in Q1, Net Profit Declines

Krishna Institute of Medical Sciences (KIMS Hospitals) reported Q1 results with total revenue up 26.8% YoY to ₹879.00 crores. However, profit after tax decreased to ₹85.00 crores from ₹95.00 crores YoY. EBITDA grew 8.5% YoY to ₹200.00 crores, but margins compressed to 22.7%. Operationally, inpatient volume grew 15.3% and outpatient volume increased 19.3% YoY. The company plans to open two new units in Bangalore next quarter. An Analyst/Institutional Investor Meeting is scheduled for August 12 in Mumbai.

14May 25

Krishna Institute of Medical Sciences Sees Major Block Trade Worth ₹51.62 Crore

Krishna Institute of Medical Sciences Ltd. (KIMS) experienced a significant block trade on the NSE. Approximately 797,020 shares were traded at ₹647.65 per share, totaling ₹51.62 crore. The identities of the parties involved and the reasons for the trade remain undisclosed. This large transaction has drawn attention from market participants, potentially indicating significant investor interest or changes in substantial shareholdings.

13May 25

Krishna Institute Of Medical Sciences Reports Robust Q4 Financial Performance

Krishna Institute Of Medical Sciences (KIMS) announced strong Q4 financial results. Consolidated net profit rose to ₹102.00 crore, up 55.73% year-over-year. Revenue increased to ₹797.00 crore, showing 25.71% growth. The healthcare provider's performance indicates improved operational efficiency and strong market position.

12May 25

Krishna Institute of Medical Sciences Reports Robust Q4 Financial Performance

Krishna Institute of Medical Sciences (KIMS) announced strong Q4 results with consolidated net profit reaching ₹1.02 billion, up 55.7% year-over-year. Revenue increased by 25.7% to ₹7.97 billion. The company also showed sequential growth with profits rising 15% from the previous quarter.

06Mar 25

Krishna Institute of Medical Sciences Sees Rs. 16.15 Crore Block Trade; Announces Investor Meeting

Krishna Institute of Medical Sciences Ltd. (KIMS) experienced a significant block trade of 306,372 shares at Rs. 527.00 per share, totaling Rs. 16.15 crores on the NSE. The company also announced an upcoming meeting with Wasatch Global Investors on March 10, 2025, in Hyderabad, complying with SEBI regulations and ensuring no unpublished price-sensitive information will be shared.

26Feb 25

KIMS Sets Ambitious 20% Growth Target for FY26 with Aggressive Expansion Plans

Krishna Institute of Medical Sciences (KIMS) has announced a growth strategy targeting 18-20% expansion by FY2026. The plan includes launching 3-4 new hospitals this fiscal year and adding 3 more through O&M contracts next year. KIMS is open to acquiring hospitals under O&M contracts with future buyout options, allowing for market testing and potential acquisitions. This strategy aims to increase market share, diversify revenue streams, and strengthen KIMS' position in the healthcare sector.

20Feb 25

KIMS Expands Footprint: Signs Operations and Management Agreement with Splendid Hospitals

Krishna Institute of Medical Sciences (KIMS) has entered into an operations and management agreement with Splendid Hospitals. KIMS will be responsible for running the hospital, managing daily operations, operating various departments, and providing comprehensive medical services. This strategic move allows KIMS to expand its operational reach without capital-intensive investments in new facilities, potentially leading to operational synergies and revenue diversification.